Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

GPhA’s Goals For 2013: Smooth GDUFA Implementation, Workable Biosimilar Pathway

19 Feb 2013

• By Sue Sutter

Related Content

GPhA's New CEO Ralph Neas Brings Health Reform Advocacy Experience

07 Sep 2011

GPhA Enters 2011 Bigger And Stronger, But With A Broader Fight On Its Hands

10 Jan 2011

FDA Biosimilars Guidances Address Immunogenicity Studies, European Bridge Data, Analytics

09 Feb 2012

GPhA’s Neas Preaches Vigilance Against Reopening Hatch-Waxman Act

20 Feb 2012

Related Companies

Teva Pharmaceutical Industries Ltd.

Additional Topics

United States Regulation Leadership BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.